Full FDA approval of Pfizer’s coronavirus vaccine might pave the way for the company to set a market price, according to a source following vaccine developments, but the government already bought enough doses to provide free boosters and shots for kids under 12, should FDA approve those indications.
Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.
Log in to access this content.
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
© 2002-2021. Inside Washington Publishers | Contact Us